Journal articles on the topic 'Preclinical tumor models'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the top 50 journal articles for your research on the topic 'Preclinical tumor models.'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.
Varticovski, L., M. G. Hollingshead, M. R. Anver, A. I. Robles, J. E. Green, K. W. Hunter, G. Merlino, et al. "Preclinical testing using tumors from genetically engineered mouse mammary models." Journal of Clinical Oncology 24, no. 18_suppl (June 20, 2006): 10067. http://dx.doi.org/10.1200/jco.2006.24.18_suppl.10067.
Klenner, Marbod, Pia Freidel, Mariella G. Filbin, and Alexander Beck. "DIPG-39. New preclinical models for Diffuse Midline Glioma." Neuro-Oncology 24, Supplement_1 (June 1, 2022): i27. http://dx.doi.org/10.1093/neuonc/noac079.096.
Costa, Alice, Livia Gozzellino, Margherita Nannini, Annalisa Astolfi, Maria Abbondanza Pantaleo, and Gianandrea Pasquinelli. "Preclinical Models of Visceral Sarcomas." Biomolecules 13, no. 11 (November 6, 2023): 1624. http://dx.doi.org/10.3390/biom13111624.
Llaguno-Munive, Monserrat, Wilberto Villalba-Abascal, Alejandro Avilés-Salas, and Patricia Garcia-Lopez. "Near-Infrared Fluorescence Imaging in Preclinical Models of Glioblastoma." Journal of Imaging 9, no. 10 (October 6, 2023): 212. http://dx.doi.org/10.3390/jimaging9100212.
Sewduth, Raj N., and Konstantina Georgelou. "Relevance of Carcinogen-Induced Preclinical Cancer Models." Journal of Xenobiotics 14, no. 1 (January 5, 2024): 96–109. http://dx.doi.org/10.3390/jox14010006.
Roosen, Mieke, Chris Meulenbroeks, Phylicia Stathi, Joris Maas, Julie Morscio, Jens Bunt, and Marcel Kool. "BIOL-11. PRECLINICAL MODELLING OF PEDIATRIC BRAIN TUMORS USING ORGANOID TECHNOLOGY." Neuro-Oncology 25, Supplement_1 (June 1, 2023): i8. http://dx.doi.org/10.1093/neuonc/noad073.030.
Stripay, Jennifer L., Thomas E. Merchant, Martine F. Roussel, and Christopher L. Tinkle. "Preclinical Models of Craniospinal Irradiation for Medulloblastoma." Cancers 12, no. 1 (January 5, 2020): 133. http://dx.doi.org/10.3390/cancers12010133.
Sitta, Juliana, Pier Paolo Claudio, and Candace M. Howard. "Virus-Based Immuno-Oncology Models." Biomedicines 10, no. 6 (June 18, 2022): 1441. http://dx.doi.org/10.3390/biomedicines10061441.
Ortiz, Michael Vincent, Armaan Siddiquee, Daoqi You, Prabhjot Singh Mundi, Lianna Marks, Kristina Guillan, Daniel Diolaiti, et al. "Preclinical evaluation of XPO1 inhibition in Wilms tumors." Journal of Clinical Oncology 38, no. 15_suppl (May 20, 2020): 3580. http://dx.doi.org/10.1200/jco.2020.38.15_suppl.3580.
Bella, Ángela, Claudia Augusta Di Trani, Myriam Fernández-Sendin, Leire Arrizabalaga, Assunta Cirella, Álvaro Teijeira, José Medina-Echeverz, Ignacio Melero, Pedro Berraondo, and Fernando Aranda. "Mouse Models of Peritoneal Carcinomatosis to Develop Clinical Applications." Cancers 13, no. 5 (February 25, 2021): 963. http://dx.doi.org/10.3390/cancers13050963.
Mahmoudian, Reihaneh Alsadat, Moein Farshchian, Fatemeh Fardi Golyan, Parvaneh Mahmoudian, Ali Alasti, Vahid Moghimi, Mina Maftooh, et al. "Preclinical tumor mouse models for studying esophageal cancer." Critical Reviews in Oncology/Hematology 189 (September 2023): 104068. http://dx.doi.org/10.1016/j.critrevonc.2023.104068.
Tada, Takuya, Thomas D. Norton, Rebecca Leibowitz, and Nathaniel R. Landau. "Checkpoint inhibitor-expressing lentiviral vaccine suppresses tumor growth in preclinical cancer models." Journal for ImmunoTherapy of Cancer 12, no. 4 (April 2024): e008761. http://dx.doi.org/10.1136/jitc-2023-008761.
Baniahmad, Aria. "Tumor spheroids and organoids as preclinical model systems." Medizinische Genetik 33, no. 3 (September 1, 2021): 229–34. http://dx.doi.org/10.1515/medgen-2021-2093.
Tellez-Gabriel, Marta, Denis Cochonneau, Marie Cadé, Camille Jubelin, Marie-Françoise Heymann, and Dominique Heymann. "Circulating Tumor Cell-Derived Pre-Clinical Models for Personalized Medicine." Cancers 11, no. 1 (December 24, 2018): 19. http://dx.doi.org/10.3390/cancers11010019.
Ehrenberg, Karl Roland, Jianpeng Gao, Felix Oppel, Stephanie Frank, Na Kang, Sebastian M. Dieter, Friederike Herbst, et al. "Systematic Generation of Patient-Derived Tumor Models in Pancreatic Cancer." Cells 8, no. 2 (February 10, 2019): 142. http://dx.doi.org/10.3390/cells8020142.
Pinto, Bárbara, Ana C. Henriques, Patrícia M. A. Silva, and Hassan Bousbaa. "Three-Dimensional Spheroids as In Vitro Preclinical Models for Cancer Research." Pharmaceutics 12, no. 12 (December 6, 2020): 1186. http://dx.doi.org/10.3390/pharmaceutics12121186.
Davy, Mélodie, Laurie Genest, Christophe Legrand, Océane Pelouin, Guillaume Froget, Vincent Castagné, and Tristan Rupp. "Evaluation of Temozolomide and Fingolimod Treatments in Glioblastoma Preclinical Models." Cancers 15, no. 18 (September 8, 2023): 4478. http://dx.doi.org/10.3390/cancers15184478.
Koptyra, Mateusz, Valerie Baubet, David Beale, Luke Patterson, Ian Biluck, Madison Hollawell, Christopher M. Beck, et al. "MODL-30. Children’s Brain Tumor Network preclinical tumor models development and sharing platform: collaborative model empowering pediatric brain tumor discovery and global research." Neuro-Oncology 24, Supplement_1 (June 1, 2022): i175—i176. http://dx.doi.org/10.1093/neuonc/noac079.653.
Mohr, Hermine, and Natalia S. Pellegata. "Animal models of MEN1." Endocrine-Related Cancer 24, no. 10 (October 2017): T161—T177. http://dx.doi.org/10.1530/erc-17-0249.
Minami, Jenna, Nicholas Bayley, Christopher Tse, Henan Zhu, Danielle Morrow, William Yong, Linda Liau, Timothy Cloughesy, Thomas Graeber, and David Nathanson. "TAMI-06. PRECLINICAL MODELS REVEAL BRAIN-MICROENVIRONMENT SPECIFIC METABOLIC DEPENDENCIES IN GLIOBLASTOMA." Neuro-Oncology 22, Supplement_2 (November 2020): ii214. http://dx.doi.org/10.1093/neuonc/noaa215.895.
Hollawell, Madison, Valerie Baubet, David Beale, Luke Patterson, Ian Biluck, Ciana Anthony, Peeyush Goel, et al. "BIOL-22. CHILDREN’S BRAIN TUMOR NETWORK PRECLINICAL TUMOR MODELS DEVELOPMENT AND SHARING PLATFORM: COLLABORATIVE MODEL EMPOWERING PEDIATRIC BRAIN TUMOR DISCOVERY AND GLOBAL RESEARCH." Neuro-Oncology 25, Supplement_1 (June 1, 2023): i10—i11. http://dx.doi.org/10.1093/neuonc/noad073.041.
Hansson, Karin, Katarzyna Radke, Kristina Aaltonen, Jani Saarela, Adriana Mañas, Jonas Sjölund, Emma M. Smith, et al. "Therapeutic targeting of KSP in preclinical models of high-risk neuroblastoma." Science Translational Medicine 12, no. 562 (September 23, 2020): eaba4434. http://dx.doi.org/10.1126/scitranslmed.aba4434.
Minami, Jenna, Nicholas Bayley, Christopher Tse, Henan Zhu, Danielle Morrow, William Yong, Linda Liau, Timothy F. Cloughesy, Thomas Graeber, and David A. Nathanson. "ETMM-02. PRECLINICAL MODELS REVEAL BRAIN-MICROENVIRONMENT SPECIFIC METABOLIC DEPENDENCIES IN GLIOBLASTOMA." Neuro-Oncology Advances 3, Supplement_1 (March 1, 2021): i14. http://dx.doi.org/10.1093/noajnl/vdab024.058.
Sgouros, George, Robert F. Hobbs, and Diane S. Abou. "The Role of Preclinical Models in Radiopharmaceutical Therapy." American Society of Clinical Oncology Educational Book, no. 34 (May 2014): e121-e125. http://dx.doi.org/10.14694/edbook_am.2014.34.e121.
Dobson, Tara, and Vidya Gopalakrishnan. "Preclinical Models of Pediatric Brain Tumors—Forging Ahead." Bioengineering 5, no. 4 (October 2, 2018): 81. http://dx.doi.org/10.3390/bioengineering5040081.
Forde, Patrick F., Mira Sadadcharam, Michael G. Bourke, Thomas A. Conway, Shane R. Guerin, Marcel de Kruijf, Gerald C. O’Sullivan, Joseph Impellizeri, Anthony J. P. Clover, and Declan M. Soden. "Preclinical evaluation of an endoscopic electroporation system." Endoscopy 48, no. 05 (April 4, 2016): 477–83. http://dx.doi.org/10.1055/s-0042-101343.
Chen, Stephen R., Frederick F. Lang, and Peter Kan. "Preclinical animal brain tumor models for interventional neuro-oncology." Journal of NeuroInterventional Surgery 14, no. 5 (April 12, 2022): neurintsurg—2022–018968. http://dx.doi.org/10.1136/neurintsurg-2022-018968.
Wu, Jianrong, and Peter J. Houghton. "Assessing Cytotoxic Treatment Effects in Preclinical Tumor Xenograft Models." Journal of Biopharmaceutical Statistics 19, no. 5 (August 7, 2009): 755–62. http://dx.doi.org/10.1080/10543400903105158.
Banerjee, Sulagna, Venugopal Thayanithy, Veena Sangwan, Tiffany N. Mackenzie, Ashok K. Saluja, and Subbaya Subramanian. "Minnelide reduces tumor burden in preclinical models of osteosarcoma." Cancer Letters 335, no. 2 (July 2013): 412–20. http://dx.doi.org/10.1016/j.canlet.2013.02.050.
Vitale, Giovanni, Silvia Carra, Ylenia Alessi, Federica Campolo, Carla Pandozzi, Isabella Zanata, Annamaria Colao, and Antongiulio Faggiano. "Carcinoid Syndrome: Preclinical Models and Future Therapeutic Strategies." International Journal of Molecular Sciences 24, no. 4 (February 10, 2023): 3610. http://dx.doi.org/10.3390/ijms24043610.
McCloskey, Curtis, Galaxia Rodriguez, Kristianne Galpin, and Barbara Vanderhyden. "Ovarian Cancer Immunotherapy: Preclinical Models and Emerging Therapeutics." Cancers 10, no. 8 (July 26, 2018): 244. http://dx.doi.org/10.3390/cancers10080244.
Dondossola, Eleonora, Andrey S. Dobroff, Serena Marchiò, Marina Cardó-Vila, Hitomi Hosoya, Steven K. Libutti, Angelo Corti, Richard L. Sidman, Wadih Arap, and Renata Pasqualini. "Self-targeting of TNF-releasing cancer cells in preclinical models of primary and metastatic tumors." Proceedings of the National Academy of Sciences 113, no. 8 (February 8, 2016): 2223–28. http://dx.doi.org/10.1073/pnas.1525697113.
Hicks, William H., Cylaina E. Bird, Jeffrey I. Traylor, Diana D. Shi, Tarek Y. El Ahmadieh, Timothy E. Richardson, Samuel K. McBrayer, and Kalil G. Abdullah. "Contemporary Mouse Models in Glioma Research." Cells 10, no. 3 (March 23, 2021): 712. http://dx.doi.org/10.3390/cells10030712.
Ernst, Kati, Konstantin Okonechnikov, Laura von Soosten, Nina Hofmann, Norman Mack, Benjamin Schwalm, Robert J. Wechsler-Reya, et al. "BIOL-07. DISTINCTIVE FEATURES OF HIGH-GRADE GLIOMA MOUSE MODELS REVEALED BY SINGLE-NUCLEUS RNA-SEQUENCING GUIDE PRE-CLINICAL MODEL SELECTION." Neuro-Oncology 25, Supplement_1 (June 1, 2023): i7. http://dx.doi.org/10.1093/neuonc/noad073.026.
Chauhan, Aman, Piotr Rychahou, Tadahide Izumi, Susanne M. Arnold, Lowell Brian Anthony, Mark Evers, and Charles Kunos. "Antitumor efficacy of M3814 as a radiation sensitizer in neuroendocrine tumor (NET) preclinical models." Journal of Clinical Oncology 37, no. 15_suppl (May 20, 2019): e15699-e15699. http://dx.doi.org/10.1200/jco.2019.37.15_suppl.e15699.
Haskell-Mendoza, Aden, Lucas Wachsmuth, and Peter Fecci. "LMAP-09 RECAPITULATING LASER INTERSTITIAL THERMAL THERAPY IN PRECLINICAL BRAIN TUMOR MODELS." Neuro-Oncology Advances 5, Supplement_3 (August 1, 2023): iii11. http://dx.doi.org/10.1093/noajnl/vdad070.040.
Lee, Jung Woo, Jia Kim, Youngjae Shin, Byung Hoon Chi, Jung Hoon Kim, and Se Young Choi. "Patient-Specific Tumor Microenvironment Models." Korean Journal of Urological Oncology 19, no. 4 (November 30, 2021): 197–222. http://dx.doi.org/10.22465/kjuo.2021.19.4.197.
Kalra, Jessica, Jennifer Baker, Justin Song, Alastair Kyle, Andrew Minchinton, and Marcel Bally. "Inter-Metastatic Heterogeneity of Tumor Marker Expression and Microenvironment Architecture in a Preclinical Cancer Model." International Journal of Molecular Sciences 22, no. 12 (June 13, 2021): 6336. http://dx.doi.org/10.3390/ijms22126336.
Spoormans, Kaat, Melissa Crabbé, Lara Struelens, Marijke De Saint-Hubert, and Michel Koole. "A Review on Tumor Control Probability (TCP) and Preclinical Dosimetry in Targeted Radionuclide Therapy (TRT)." Pharmaceutics 14, no. 10 (September 22, 2022): 2007. http://dx.doi.org/10.3390/pharmaceutics14102007.
Barachini, Serena, Mariangela Morelli, Orazio Santo Santonocito, and Chiara Maria Mazzanti. "Preclinical glioma models in neuro-oncology: enhancing translational research." Current Opinion in Oncology 35, no. 6 (September 1, 2023): 536–42. http://dx.doi.org/10.1097/cco.0000000000000997.
Kemper, Kristel, Ellis Gielen, Peter Boross, Mischa Houtkamp, Theo S. Plantinga, Stefanie AH de Poot, Saskia M. Burm, et al. "Mechanistic and pharmacodynamic studies of DuoBody-CD3x5T4 in preclinical tumor models." Life Science Alliance 5, no. 11 (September 8, 2022): e202201481. http://dx.doi.org/10.26508/lsa.202201481.
Golebiewska, Anna, Ann-Christin Hau, Anais Oudin, Daniel Stieber, Yahaya A. Yabo, Yong-Jun Kwon, Barbara Klink, et al. "TMOD-08. PRIMARY AND RECURRENT GLIOMA PATIENT-DERIVED ORTHOTOPIC XENOGRAFTS (PDOX) REPRESENT RELEVANT PATIENT AVATARS FOR PRECISION MEDICINE." Neuro-Oncology 22, Supplement_2 (November 2020): ii229. http://dx.doi.org/10.1093/neuonc/noaa215.959.
Yu, Rong, Ewetse Paul Maswikiti, Yang Yu, Lei Gao, Chenhui Ma, Huanhuan Ma, Xiaobo Deng, Na Wang, Bofang Wang, and Hao Chen. "Advances in the Application of Preclinical Models in Photodynamic Therapy for Tumor: A Narrative Review." Pharmaceutics 15, no. 1 (January 5, 2023): 197. http://dx.doi.org/10.3390/pharmaceutics15010197.
Saito, Yasuyuki, Afroj Tania, Satomi Komori, Tomoko Takai, Okechi S. Oduori, Takenori Kotani, Yohei Funakoshi, et al. "Preclinical Evaluation of the Efficacy of Human Sirpα Antibodies for B-Cell Lymphoma Immunotherapy in Humanized Mouse Models." Blood 142, Supplement 1 (November 28, 2023): 1646. http://dx.doi.org/10.1182/blood-2023-181926.
Zhu, Menghan, Nan Jia, Yanyan Nie, Jun Chen, Yahui Jiang, Tianjiao Lv, Yuanyuan Li, Liangqing Yao, and Weiwei Feng. "Establishment of Patient-Derived Tumor Xenograft Models of High-Risk Endometrial Cancer." International Journal of Gynecologic Cancer 28, no. 9 (November 2018): 1812–20. http://dx.doi.org/10.1097/igc.0000000000001365.
Matei, Daniela. "Abstract IA018: Epigenome targeting in ovarian cancer: preclinical models to clinic." Cancer Research 84, no. 5_Supplement_2 (March 4, 2024): IA018. http://dx.doi.org/10.1158/1538-7445.ovarian23-ia018.
Iaia, Ilenia, Loretta Gammaitoni, Giulia Cattaneo, Lidia Giraudo, Chiara Donini, Erika Fiorino, Luca Primo, et al. "Recruitment, Infiltration, and Cytotoxicity of HLA-Independent Killer Lymphocytes in Three-Dimensional Melanoma Models." Cancers 13, no. 10 (May 11, 2021): 2302. http://dx.doi.org/10.3390/cancers13102302.
Grausam, Katie, David Rincon Fernandez Pacheco, Emily Hatanaka, Stephen Shiao, and Joshua Breunig. "MODL-34. A SERIES OF EGFR-MUTANT MODELS OF GLIOBLASTOMA THAT RECAPITULATES PATIENT TUMOR HETEROGENEITY AND RESPONSE TO TREATMENT." Neuro-Oncology 25, Supplement_5 (November 1, 2023): v306. http://dx.doi.org/10.1093/neuonc/noad179.1185.
Odunsi, Adekunle, A. J. Robert McGray, Anthony Miliotto, Yali Zhang, Jianming Wang, Adebukola Abiola, Cheryl Eppolito, and Ruea-Yea Huang. "Fidelity of human ovarian cancer patient-derived xenografts in a partially humanized mouse model for preclinical testing of immunotherapies." Journal for ImmunoTherapy of Cancer 8, no. 2 (November 2020): e001237. http://dx.doi.org/10.1136/jitc-2020-001237.
Franklin, M., M. Thayer, D. Draper, D. Saims, and S. Wise. "Preclinical assessment of anti-tumor activity and immune response in syngeneic tumor models." European Journal of Cancer 69 (December 2016): S97. http://dx.doi.org/10.1016/s0959-8049(16)32887-8.